Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors

por Sacco, Assuntina G, Worden, Francis P
Publicado 2016

Access Denied: Disparities in Thyroid Cancer Clinical Trials

por Chen, Debbie W, Worden, Francis P, Haymart, Megan R
Publicado 2023

SAT518 Real World Use of Systemic Therapy for Treatment of Advanced Thyroid Cancer

por Chen, Debbie, Banerjee, Mousumi, Xu, Tianyi, Worden, Francis P, Haymart, Megan R
Publicado 2023

Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States

por Dacosta Byfield, Stacey A., Adejoro, Oluwakayode, Copher, Ronda, Chatterjee, Debanjana, Joshi, Prashant R., Worden, Francis P.
Publicado 2019

Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical...

por Habra, Mouhammed Amir, Hammer, Gary D, Kebebew, Electron, Worden, Francis P, Raj, Nitya, Hallanger-Johnson, Julie E, Grauer, Andreas, Moraitis, Andreas
Publicado 2021

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio...

por Popovtzer, Aron, Normolle, Daniel, Worden, Francis P., Prince, Mark E., Chepeha, Douglas B., Wolf, Gregory T., Bradford, Carol R., Lawrence, Theodore S., Eisbruch, Avraham
Publicado 2014

Feasibility of Non-invasive Brain Modulation for Management of Pain Related to Chemoradiotherapy in Patients with Advanced Head and Neck Cancer

por Hu, Xiao-Su, Fisher, Clayton A., Munz, Stephanie M., Toback, Rebecca L., Nascimento, Thiago D., Bellile, Emily L., Rozek, Laura, Eisbruch, Avraham, Worden, Francis P., Danciu, Theodora E., DaSilva, Alexandre F.
Publicado 2016

Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial

por Kahana, Alon, Unsworth, Shelby P., Andrews, Christopher A., Chan, May P., Bresler, Scott C., Bichakjian, Christopher K., Durham, Alison B., Demirci, Hakan, Elner, Victor M., Nelson, Christine C., Kim, Denise S., Joseph, Shannon S., Swiecicki, Paul L., Worden, Francis P.
Publicado 2021

Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma

por Haring, Catherine T., Bhambhani, Chandan, Brummel, Collin, Jewell, Brittany, Bellile, Emily, Heft Neal, Molly E., Sandford, Erin, Spengler, Ryan M., Bhangale, Apurva, Spector, Matthew E., McHugh, Jonathan, Prince, Mark E., Mierzwa, Michelle, Worden, Francis P., Tewari, Muneesh, Swiecicki, Paul L., Brenner, J. Chad
Publicado 2021

Biomarkers predictive of response to pembrolizumab in head and neck cancer

por Pfister, David G., Haddad, Robert I., Worden, Francis P., Weiss, Jared, Mehra, Ranee, Chow, Laura Q. M., Liu, Stephen V., Kang, Hyunseok, Saba, Nabil F., Wirth, Lori J., Sukari, Ammar, Massarelli, Erminia, Ayers, Mark, Albright, Andrew, Webber, Andrea L., Mogg, Robin, Lunceford, Jared, Huang, Lingkang, Cristescu, Razvan, Cheng, Jonathan, Seiwert, Tanguy Y., Bauml, Joshua M.
Publicado 2022